JPMorgan Chase & Co’s Prometheus Biosciences, Inc. Common Stock RXDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-101,586
| Closed | -$10.9M | – | 6403 |
|
|
2023
Q1 | $10.9M | Sell |
101,586
-25,489
| -20% | -$2.74M | ﹤0.01% | 1929 |
|
|
2022
Q4 | $14M | Buy |
127,075
+44,966
| +55% | +$4.95M | ﹤0.01% | 1669 |
|
|
2022
Q3 | $4.85M | Sell |
82,109
-291
| -0.4% | -$17.2K | ﹤0.01% | 2358 |
|
|
2022
Q2 | $2.33M | Sell |
82,400
-527
| -0.6% | -$14.9K | ﹤0.01% | 2903 |
|
|
2022
Q1 | $3.13M | Buy |
82,927
+67,975
| +455% | +$2.57M | ﹤0.01% | 2884 |
|
|
2021
Q4 | $591K | Buy |
14,952
+10,606
| +244% | +$419K | ﹤0.01% | 3964 |
|
|
2021
Q3 | $103K | Sell |
4,346
-2,476
| -36% | -$58.7K | ﹤0.01% | 4702 |
|
|
2021
Q2 | $168K | Buy |
+6,822
| New | +$168K | ﹤0.01% | 4572 |
|